BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

MedTech Baymatob completes capital raise to advance life-saving labor monitoring device

Cornerstoned by Australian Unity's Future of Healthcare Fund, the placement was strongly supported by institutional and high net worth investors, securing ...

March 30, 2022 | News

New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer

The X-Cancer's investigator-led trial of SAR-bisPSMA in known or suspected prostate cancer (X-Calibur) is a Phase I/II IIT in up to 150 patients at the Uro...

March 25, 2022 | News

Telix Advances Development of Glioblastoma Therapy Program

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...

March 23, 2022 | News

PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial

The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...

February 28, 2022 | News

TGA Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)

"The TGA authorization for the use of our COVID-19 vaccine in children 6-11 years old in Australia is an important milestone for Moderna as it is the first...

February 18, 2022 | News

Visionflex Chooses Vonage to Power its Next-Generation Remote Healthcare and Diagnostic Services

Based in Australia, Visionflex is a telehealth innovator with a mission to deliver quality healthcare to everyone, everywhere. Visionflex's powerful s...

February 14, 2022 | News

Antengene Announces HREC Approval in Australia

ATG-037 is the first orally-available, small molecule CD73 inhibitor to advance to clinical-stage by a Chinese company - The Phase I study will evaluate A...

February 07, 2022 | News

Cytiva fuels biotech development in Australia and New Zealand

Cytiva, a global life sciences leader, announces the winner of its first BioChallenge for the Australia and New Zealand region (ANZ). T...

February 01, 2022 | News

Australia approves Pfizer booster for 16–17 year olds

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people aged 16–17 years old. The adv...

January 31, 2022 | News

Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

January 20, 2022 | News

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive ...

January 18, 2022 | News

How to Choose the Right At-Home COVID Test

Insight follows announcement that the Biden administration will purchase 500 million rapid COVID-19 tests and distribute free of cost to Americans With th...

December 22, 2021 | News

TCM provides new alternatives for the fight against COVID-19

Dr. Chen Zhen, President of the Central and Eastern European Federation of Chinese Medicine Societies, said that the Hungarian Qihuang TCM Center prov...

December 22, 2021 | News

Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA

he hypothesis-free testing method, MetaPanelTM, can identify multiple pathogens simultaneously from a single sample and was developed in partnership with A...

December 20, 2021 | News

Stay Connected